(Q33360655)
Statements
1 reference
A phase 1 study of OSI-211 given as an intravenous infusion days 1, 2, and 3 every three weeks in patients with solid cancers (English)
1 reference
Gelmon K
1 reference
Hirte H
1 reference
Fisher B
1 reference
Walsh W
1 reference
Ptaszynski M
1 reference
Hamilton M
1 reference
Onetto N
1 reference
Eisenhauer E
1 reference
1 August 2004
1 reference
1 reference
22
1 reference
263-275
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference